Jean‐Paul Eschard

945 total citations
29 papers, 642 citations indexed

About

Jean‐Paul Eschard is a scholar working on Surgery, Rheumatology and Oncology. According to data from OpenAlex, Jean‐Paul Eschard has authored 29 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 8 papers in Rheumatology and 7 papers in Oncology. Recurrent topics in Jean‐Paul Eschard's work include Infectious Diseases and Tuberculosis (6 papers), Orthopedic Infections and Treatments (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Jean‐Paul Eschard is often cited by papers focused on Infectious Diseases and Tuberculosis (6 papers), Orthopedic Infections and Treatments (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Jean‐Paul Eschard collaborates with scholars based in France and Belgium. Jean‐Paul Eschard's co-authors include Jean‐Hugues Salmon, Lotfi Benboubker, Mamoun Dib, Cyrille Hulin, Bruno César Corrêa Salles, Thierry Façon, Laurent Garderet, Philippe Casassus, I Azaïs and Philippe Rodon and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Pathology and Lara D. Veeken.

In The Last Decade

Jean‐Paul Eschard

28 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Paul Eschard France 12 284 260 217 129 85 29 642
M Andolina Italy 16 198 0.7× 215 0.8× 158 0.7× 106 0.8× 31 0.4× 47 738
Debby den Uyl Netherlands 13 129 0.5× 219 0.8× 121 0.6× 68 0.5× 330 3.9× 21 770
Edgardo Angtuaco United States 7 440 1.5× 246 0.9× 300 1.4× 52 0.4× 18 0.2× 14 645
A. Widmer Switzerland 8 467 1.6× 682 2.6× 110 0.5× 120 0.9× 387 4.6× 14 1.3k
Stephanie Gregory United States 13 331 1.2× 174 0.7× 379 1.7× 63 0.5× 19 0.2× 26 963
Haruko Ideguchi Japan 16 93 0.3× 259 1.0× 114 0.5× 95 0.7× 338 4.0× 43 913
Gaël Mouterde France 18 223 0.8× 71 0.3× 174 0.8× 98 0.8× 464 5.5× 43 841
Herbert Kellner Germany 17 307 1.1× 137 0.5× 108 0.5× 97 0.8× 762 9.0× 38 1.2k
Beáta Dérfalvi Canada 14 140 0.5× 193 0.7× 46 0.2× 52 0.4× 144 1.7× 37 644
A. Nzeusseu Toukap Belgium 14 144 0.5× 104 0.4× 114 0.5× 43 0.3× 549 6.5× 36 784

Countries citing papers authored by Jean‐Paul Eschard

Since Specialization
Citations

This map shows the geographic impact of Jean‐Paul Eschard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Paul Eschard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Paul Eschard more than expected).

Fields of papers citing papers by Jean‐Paul Eschard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Paul Eschard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Paul Eschard. The network helps show where Jean‐Paul Eschard may publish in the future.

Co-authorship network of co-authors of Jean‐Paul Eschard

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Paul Eschard. A scholar is included among the top collaborators of Jean‐Paul Eschard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Paul Eschard. Jean‐Paul Eschard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Salmon, Jean‐Hugues, Jean‐Paul Eschard, Vincent Goëb, et al.. (2019). Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study. Rheumatology and Therapy. 6(1). 61–75. 11 indexed citations
3.
Salmon, Jean‐Hugues, et al.. (2018). Cost Effectiveness of Intra-Articular Hyaluronic Acid and Disease-Modifying Drugs in Knee Osteoarthritis. PharmacoEconomics. 36(11). 1321–1331. 11 indexed citations
4.
5.
Michel, M., et al.. (2016). Ustekinumab dans le rhumatisme psoriasique après échec des anti-TNFα en pratique courante. Therapies. 71(3). 281–286. 3 indexed citations
6.
7.
Pham, Bach‐Nga, et al.. (2016). L’analyse des difficultés du parcours des étudiants en médecine dans les facultés de médecine françaises. Pédagogie médicale. 17(3). 147–156. 3 indexed citations
8.
Pennaforte, Jean‐Loup, et al.. (2015). Failure of tocilizumab therapy in a patient with mouth and genital ulcers with inflamed cartilage syndrome complicated by aortic aneurysm: Table 1. Lara D. Veeken. 54(11). 2111–2113. 9 indexed citations
9.
Salmon, Jean‐Hugues, et al.. (2012). Discitis and sacroiliitis diagnosed 15years after iatrogenic Mycobacterium xenopi inoculation. Joint Bone Spine. 79(4). 409–411. 9 indexed citations
10.
Hulin, Cyrille, Thierry Façon, Philippe Rodon, et al.. (2009). Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial. Journal of Clinical Oncology. 27(22). 3664–3670. 266 indexed citations
11.
Papathanassiou, Dimitri, et al.. (2009). Single-photon emission computed tomography combined with computed tomography (SPECT/CT) in bone diseases. Joint Bone Spine. 76(5). 474–480. 52 indexed citations
12.
Papathanassiou, Dimitri, et al.. (2009). Tomographie d’émission monophotonique couplée au scanner et pathologie osseuse. Revue du Rhumatisme. 76(9). 843–850. 1 indexed citations
13.
Eschard, Jean‐Paul, et al.. (2009). Neurogenic muscle hypertrophy. Joint Bone Spine. 76(4). 401–403. 9 indexed citations
14.
Thiéfin, Gérard, et al.. (2008). Infliximab-induced hepatitis: absence of cross-toxicity with etanercept. Joint Bone Spine. 75(6). 737–739. 39 indexed citations
15.
Boyer, F., et al.. (2007). Efficacité de la nucléolyse laser dans le traitement des radiculalgies par hernie discale (149 patients). La Presse Médicale. 36(11). 1527–1535. 5 indexed citations
16.
Durlach, A., et al.. (2006). Chronic monoarthritis and previous history of cancer: think about synovial metastasis. Clinical Rheumatology. 26(1). 60–63. 17 indexed citations
17.
Strady, C., et al.. (2006). Tuberculose lors d'un traitement par agents inhibiteurs du TNF alpha. La Presse Médicale. 35(11). 1765–1772. 9 indexed citations
18.
Eschard, Jean‐Paul, et al.. (2005). Facteurs pronostiques du myélome utilisables en pratique courante : suivi sur dix ans de 148 malades âgés de plus de 55 ans. Revue du Rhumatisme. 72(12). 1299–1305. 3 indexed citations
19.
Chappard, Daniel, Érick Legrand, Gérard Chalès, et al.. (2001). Fractal dimension of trabecular bone: comparison of three histomorphometric computed techniques for measuring the architectural two‐dimensional complexity. The Journal of Pathology. 195(4). 515–521. 72 indexed citations
20.
Léone, J., Jean‐Pierre Vilque, B. Pignon, et al.. (1996). Avascular necrosis of the femoral head as a complication of chronic myelogenous leukaemia. Skeletal Radiology. 25(7). 696–698. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Andolina Breakdown of academic impact, for papers by Debby den Uyl Breakdown of academic impact, for papers by Edgardo Angtuaco Breakdown of academic impact, for papers by A. Widmer Breakdown of academic impact, for papers by Stephanie Gregory Breakdown of academic impact, for papers by Haruko Ideguchi Breakdown of academic impact, for papers by Gaël Mouterde Breakdown of academic impact, for papers by Herbert Kellner Breakdown of academic impact, for papers by Beáta Dérfalvi Breakdown of academic impact, for papers by A. Nzeusseu Toukap
Rankless by CCL
2026